ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,642Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 49

$413K Total Retail Price of All Prescriptions

Rank: 12 out of 49

446 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wyoming
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 446 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

14% of this provider’s 446 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 10,423 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$35 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wyoming
SPIRONOLACTONE 550 514 1 26
LEVOTHYROXINE SODIUM 466 442 2 1
CITALOPRAM HBR 459 417 3 18
OMEPRAZOLE 408 372 4 4
GABAPENTIN 382 365 5 15
FUROSEMIDE 352 327 6 5
HYDROCODONE-ACETAMINOPHEN 348 277 S3 7 7
WARFARIN SODIUM 335 303 8 8
MELOXICAM 309 264 9 31
LISINOPRIL 284 268 10 3
SIMVASTATIN 262 247 11 2
METFORMIN HCL 250 208 12 10
METOPROLOL SUCCINATE 237 221 13 16
METFORMIN HCL ER 215 198 14 38
TRAMADOL HCL 214 170 15 29
DONEPEZIL HCL 200 200 16 24
AMLODIPINE BESYLATE 197 183 17 6
RANITIDINE HCL 183 154 18 64
PREDNISONE 174 155 19 30
MIRTAZAPINE 174 160 19 53
METOPROLOL TARTRATE 174 147 19 11
LISINOPRIL-HYDROCHLOROTHIAZIDE 170 142 22 34
QUETIAPINE FUMARATE 161 136 23 71
ZOLPIDEM TARTRATE 150 110 24 19
HYDROCHLOROTHIAZIDE 144 139 25 12
TAMSULOSIN HCL 128 125 26 25
OXYBUTYNIN CHLORIDE 127 113 27 82
SPIRONOLACTONE-HCTZ 116 100 28 69
LOSARTAN POTASSIUM 112 104 29 14
LANTUS 98 87 30 48
LOSARTAN-HYDROCHLOROTHIAZIDE 91 91 31 40
ADVAIR DISKUS 90 87 32 28
NAMENDA 90 90 32 41
OXYBUTYNIN CHLORIDE ER 90 77 32 131
SPIRIVA 88 80 35 37
PRAVASTATIN SODIUM 83 78 36 20
MORPHINE SULFATE ER 80 68 S2 37 137
NORTRIPTYLINE HCL 78 67 38 141
CARBIDOPA-LEVODOPA 72 61 39 94
PANTOPRAZOLE SODIUM 70 63 40 32
SEROQUEL 68 64 41 146
CARVEDILOL 67 67 42 35
CLOPIDOGREL 66 66 43 46
GLIMEPIRIDE 65 61 44 49
ATORVASTATIN CALCIUM 65 50 44 13
TRAZODONE HCL 65 62 44 54
ALENDRONATE SODIUM 64 63 47 36
DILTIAZEM 24HR CD 64 64 47 65
INSULIN SYRINGE 62 51 49 154
SERTRALINE HCL 61 61 50 22
CIPROFLOXACIN HCL 55 49 51 76
AZITHROMYCIN 55 49 51 47
ALLOPURINOL 51 51 53 21
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 1, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.